Works matching IS 09414355 AND DT 2012 AND VI 20 AND IP 7


Results: 29
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study.

    Published in:
    Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1471, doi. 10.1007/s00520-011-1235-4
    By:
    • Hesketh, Paul;
    • Wright, Oliver;
    • Rosati, Gerardo;
    • Russo, Mark;
    • Levin, Jeremey;
    • Lane, Stephen;
    • Moiseyenko, Vladimir;
    • Dube, Pierre;
    • Kopp, Mikhail;
    • Makhson, Anatoly
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.

    Published in:
    Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1395, doi. 10.1007/s00520-012-1451-6
    By:
    • Reguiai, Z.;
    • Bachet, J.;
    • Bachmeyer, C.;
    • Peuvrel, L.;
    • Beylot-Barry, M.;
    • Bezier, M.;
    • Boucher, E.;
    • Chevelle, C.;
    • Colin, P.;
    • Guimbaud, R.;
    • Mineur, L.;
    • Richard, M.;
    • Artru, P.;
    • Dufour, P.;
    • Gornet, J.;
    • Samalin, E.;
    • Bensadoun, R.;
    • Ychou, M.;
    • André, T.;
    • Dreno, B.
    Publication type:
    Article
    28
    29